Login to Your Account

Patent Disclosures

Wednesday, November 20, 2013

• Bioalliance Pharma SA, of Paris, was issued a South Korean patent for Sitavig (acyclovir mucoadhesive tablet) for treating recurrent labial herpes in adults. The patent is based on the product’s original manufacturing process, which gives Sitavig its adhering property.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription